Clinical Trials Logo

Placenta Previa clinical trials

View clinical trials related to Placenta Previa.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06219564 Completed - Maternal; Procedure Clinical Trials

Total Placenta Previa Associated With the Placenta Accreta Spectrum.

PAS
Start date: November 1, 2017
Phase: N/A
Study type: Interventional

To assess the reliability of placental magnetic resonance imaging measurements in predicting peripartum hysterectomy and neonatal outcomes in patients with total placenta previa.

NCT ID: NCT06029985 Completed - Placenta Accreta Clinical Trials

Hysteroscopic Follow-up Following Conservative Stepwise Surgical Approach for Management of Placenta Previa Accreta

Start date: June 1, 2020
Phase:
Study type: Observational

Conservative management of placenta accreta spectrum can preserve future fertility but should only be done in hospitals with enough experience as it carries a high risk of maternal complications. Follow up after conservative management is crucial to detect complications early.

NCT ID: NCT05688111 Completed - Clinical trials for Interventional Drug in Placenta Previa

Tranexamic Acid as an Intervention in Placenta Previa

Start date: January 10, 2022
Phase: N/A
Study type: Interventional

Antepartum hemorrhage (APH) due to placenta previa is an important cause of worldwide perinatal mortality and maternal morbidity in pregnant women

NCT ID: NCT05500404 Completed - Clinical trials for Placenta Accreta Spectrum

Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study

Start date: December 1, 2021
Phase:
Study type: Observational

Current prenatal diagnosis of placenta accrete spectrum disorders relies on subjective individual interpretations of visual sonographic findings on grayscale and color Doppler imaging. When blinded to clinical data, there is significant interobserver variability in the diagnosis of invasive placentation. This study will evaluate placental thickness among pregnant women with placenta previa and determine if increased placenta thickness correlates with the risk for placenta accreta spectrum (PAS) disorders.

NCT ID: NCT05340205 Completed - Placenta Previa Clinical Trials

Blood Loss During Cesarean Delivery in Placenta Previa Patients

Start date: May 4, 2022
Phase: Phase 4
Study type: Interventional

To compare the efficacy and safety profile of intravenous tranexamic acid versus intrauterine misoprostol in reducing the blood loss during and after cesarean delivery in pregnant women diagnosed with placenta previa

NCT ID: NCT05283122 Completed - Placenta Previa Clinical Trials

Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases

Start date: March 24, 2022
Phase: N/A
Study type: Interventional

Post - partum haemorrhage is still a headache to all obstetricians around the whole world . Every obstetrician exerts his own full effort to control bleeding which can occur post-partum by applying all maneuvers to preserve the fertility and the uterus for the patient . demonstration of ( Mostafa Maged ) technique is applied to control and prevent post-partum haemorrhage . It is so simple maneuver and easy to be applied within short period of time .Satisfactory hemostasis can be assessed after application .

NCT ID: NCT05133167 Completed - Placenta Previa Clinical Trials

Balloon Tamponade Vs B-Lynch In Placenta Previa

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Patients were allocated to group A and B. In group A, balloon tamponade (using Foley catheter 28 Fr) was used intra-operatively to prevent post-partum hemorrhage. In group B, B lynch suture was used intra-operatively to prevent post-partum hemorrhage.

NCT ID: NCT04725929 Completed - Placenta Previa Clinical Trials

Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women

Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

Placenta praevia is associated with an increased risk of preterm delivery (PTD) especially if associated with bleeding and uterine contractions . In this study we will determine the effect of Progesterone in preventing a second attack of antepartum haemorrhage in pregnant women diagnosed with placenta previa

NCT ID: NCT04660578 Completed - Placenta Accreta Clinical Trials

A.Chohan Continuous Squeezing Suture (ACCSS) for Placenta Previa / Accreta

ACCSS
Start date: February 12, 2019
Phase: N/A
Study type: Interventional

Placenta praevia and accreta spectrum disorders are rising in incidence due to increased rate of repeat caesarean sections. Peripartum hysterectomy remains the only definitive treatment of massive postpartum haemorrhage related to this condition. A multitude of conservative treatments is described in literature, which includes pelvic devascularization under radiological control, myometrial resection with placenta in situ, and various suturing techniques some involving inversion of cervix. Variable success rates are described, but search continues for a simple, safe and effective treatment. Such a surgical technique i.e. A. Chohan Continuous Squeezing Suture (ACCSS) is described in this study for controlling haemorrhage from the lower uterine segment at caesarean section for placenta praevia and accrete spectrum disorders.

NCT ID: NCT04599868 Completed - Clinical trials for Placenta Previa Bleeding

High Versus Low Dose of Magnesium Sulfate as Initial Tocolytic Agent for Preterm Labour in Symptomatic Placenta Previa.

Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety of alternative magnesium sulfate regimens when used as single agent tocolytic therapy for prevention of preterm labour in patients with symptomatic placenta previa and subsequent changes in the cervical length .